Cargando…
A Prognostic Nomogram for T3N0 Rectal Cancer After Total Mesorectal Excision to Help Select Patients for Adjuvant Therapy
BACKGROUND: The recurrence rate of T3N0 rectal cancer after total mesorectal excision (TME) is relatively low, meaning that not all patients need adjuvant therapy (AT) (radiotherapy, chemotherapy, or chemoradiotherapy). METHODS: Patients diagnosed with pT3N0M0 rectal cancer after TME were analyzed u...
Autores principales: | Zhang, Chao, Zhao, Shutao, Wang, Xudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654784/ https://www.ncbi.nlm.nih.gov/pubmed/34900666 http://dx.doi.org/10.3389/fonc.2021.698866 |
Ejemplares similares
-
Oncologic Nomogram for Stage I Rectal Cancer to Assist Patient Selection for Adjuvant (Chemo)Radiotherapy Following Local Excision
por: Zhao, Shutao, et al.
Publicado: (2021) -
Learning Curve of Robotic-Assisted Total Mesorectal Excision for Rectal Cancer
por: Tang, Bo, et al.
Publicado: (2022) -
A systematic review and meta-analysis of minimally invasive total mesorectal excision versus transanal total mesorectal excision for mid and low rectal cancer
por: Gang, Du Yong, et al.
Publicado: (2023) -
In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer
por: Wu, Jun-xin, et al.
Publicado: (2014) -
A Postsurgical Prognostic Nomogram for Locally Advanced Rectosigmoid Cancer to Assist in Patient Selection for Adjuvant Chemotherapy
por: Zhang, Chao, et al.
Publicado: (2021)